243 related articles for article (PubMed ID: 32073653)
1. Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.
Bair SM; Brandstadter JD; Ayers EC; Stadtmauer EA
Cancer; 2020 Jan; 126(9):1837-1855. PubMed ID: 32073653
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Maintenance Strategies After Hematopoietic Cell Transplantation.
Culos KA; Gatwood KS; Byrne M
Pharmacotherapy; 2020 Aug; 40(8):727-740. PubMed ID: 32343426
[TBL] [Abstract][Full Text] [Related]
4. Stop and go: hematopoietic cell transplantation in the era of chimeric antigen receptor T cells and checkpoint inhibitors.
Ghosh A; Politikos I; Perales MA
Curr Opin Oncol; 2017 Nov; 29(6):474-483. PubMed ID: 28872470
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.
Bleakley M; Turtle CJ; Riddell SR
Expert Rev Hematol; 2012 Aug; 5(4):409-25. PubMed ID: 22992235
[TBL] [Abstract][Full Text] [Related]
6. Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies.
Xiong Y; Bensoussan D; Decot V
Transfus Med Rev; 2015 Oct; 29(4):259-67. PubMed ID: 26282736
[TBL] [Abstract][Full Text] [Related]
7. Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?
Hamadani M
Bone Marrow Transplant; 2013 Aug; 48(8):1013-21. PubMed ID: 23000653
[TBL] [Abstract][Full Text] [Related]
8. What the internist should know about stem cell transplant in the elderly patient.
Medinger M; Passweg J
Eur J Intern Med; 2018 Dec; 58():43-47. PubMed ID: 29960832
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
10. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
Majhail NS; Farnia SH; Carpenter PA; Champlin RE; Crawford S; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Savani BN; Veys PA; Bredeson CN; Giralt SA; LeMaistre CF
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1863-1869. PubMed ID: 26256941
[TBL] [Abstract][Full Text] [Related]
11. Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation.
Porter DL; Hexner EO; Cooley S; Miller JS
Cancer Treat Res; 2009; 144():497-537. PubMed ID: 19779876
[No Abstract] [Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation as consolidation immunotherapy of cancer after autologous transplantation.
Maris MB; Storb R
Acta Haematol; 2005; 114(4):221-9. PubMed ID: 16269862
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in novel radioimmunotherapeutic approaches for allogeneic hematopoietic cell transplantation.
Shenoi J; Gopal AK; Press OW; Pagel JM
Curr Opin Oncol; 2010 Mar; 22(2):143-9. PubMed ID: 20019612
[TBL] [Abstract][Full Text] [Related]
15. Old and new cancers after hematopoietic-cell transplantation.
Majhail NS
Hematology Am Soc Hematol Educ Program; 2008; ():142-9. PubMed ID: 19074072
[TBL] [Abstract][Full Text] [Related]
16. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Shah N; Callander N; Ganguly S; Gul Z; Hamadani M; Costa L; Sengsayadeth S; Abidi M; Hari P; Mohty M; Chen YB; Koreth J; Landau H; Lazarus H; Leather H; Majhail N; Nath R; Osman K; Perales MA; Schriber J; Shaughnessy P; Vesole D; Vij R; Wingard J; Giralt S; Savani BN;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1155-66. PubMed ID: 25769794
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation in Europe 1998.
Gratwohl A; Passweg J; Baldomero H; Hermans J; Urbano-Ispizua A;
Hematol J; 2000; 1(5):333-50. PubMed ID: 11920211
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.
Sohn SK; Jung JT; Kim DH; Lee NY; Seo KW; Chae YS; Park SW; Kim JG; Suh JS; Lee KB
Cancer; 2002 Jan; 94(1):18-24. PubMed ID: 11815956
[TBL] [Abstract][Full Text] [Related]
20. Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies.
Mehta PA; Rotz SJ; Majhail NS
Biol Blood Marrow Transplant; 2018 Dec; 24(12):e11-e19. PubMed ID: 30244107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
